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During mammalian embryogenesis, hematopoietic stem and progenitor cells (HSPCs) 
originate from mesoderm-derived endothelial cells in the aorta-gonad-mesonephros (AGM) 
region and placenta. Later, HSPCs expand in fetal liver and migrate to bone marrow shortly 
before birth. Understanding global transcriptional regulation governing HSPC emergence 
from embryonic stem/induced pluripotent stem cells is necessary to devise clinical 
applications, such as novel transplantation approaches. Here, to assess transcriptional 
dynamics during development, we performed cap analysis of gene expression (CAGE) on 10 
developmental murine HSPC populations isolated from the AGM region, placenta, fetal liver 
and bone marrow and identified 15,681 transcripts across HSPC ontogeny. We performed 
microarray analysis of AGM-derived HSPCs at 9.5 and 10.5 dpc and identified 40 
differentially-expressed genes, 23 confirmed as significantly changed by real-time PCR. We 
conclude that a transcriptional switch point occurs in HSPC ontogeny between 9.5 and 10.5 
dpc in the AGM region. 







































































































































































Hematopoietic stem cells (HSCs) either self-renew or differentiate into all blood cell 
types. How HSCs maintain a balance between self-renewal and differentiation capacity 
throughout their lifespan is a key area of investigation [1]. During mammalian 
embryogenesis, HSCs emerge through a complex process involving ontogenesis at distinct 
anatomical sites including the yolk sac, the aorta-gonad-mesonephros (AGM) region, 
placenta (PL) and fetal liver (FL), culminating at birth in colonization of bone marrow (BM) 
[2]. Understanding molecular mechanisms regulating these steps could have direct clinical 
applications for HSC transplantation therapy. Decades of research investigating HSC 
developmental stages and biology demonstrate that intrinsic signals and niche factors regulate 
these transcriptional programs [3-5], but the genome-wide picture of the transcriptional 
network governing HSC development and maturation remained far from complete. 
In combination with sensitive, well-defined assays based on microarray technology, 
RNA sequencing and serial analysis of gene expression (SAGE), researchers previously 
defined transcriptional control mechanisms regulating transient hematopoietic stem and 
progenitor cell (HSPC) populations [6,7]. However, difficulty in obtaining sufficient amounts 
of nucleic acid material for subsequent analysis has limited research progress. In addition, 
researchers found it challenging to compare lists of differentially-regulated genes due to use 
of different cell populations or HSC classification criteria.  
Cap analysis of gene expression (CAGE) sequencing is a method used to identify the 
5’ends of capped RNAs based on cap-trapping and hence provides a means to detect likely 
promoter regions [8]. Here, as part of the FANTOM5 project [9-11], we utilized CAGE 
sequencing to examine primary murine HSPCs derived from ten spatially-or temporally-
critical locations during HSPC development, including the para-aortic-splanchnopleural (p-
Sp) region at 8.5 dpc; AGM region at 9.5, 10.5 and 11.5 dpc; PL at 11.5 dpc; FL at 12.5, 
14.5 and 19.5 dpc; and BM at 2 to 3-months-old and at 2-years-old. Genome-wide expression 
profiles of HSPC samples generated from single-molecule CAGE sequencing [12] revealed 
15,681 transcription start sites (TSSs). The ten groups were clustered as pre-HSPCs, 
definitive HSPCs, fetal HSPCs and adult HSPCs, allowing further generation of signature 
gene lists for each stage. The 15,681 TSSs mapped to 10,385 genes, highlighting an 
abundance of alternate transcripts and indicating that major changes in the transcriptome 






















































































































































occur in the AGM region from 9.5 to 10.5 dpc. Due to the requirement for a large number of 
embryos for CAGE sequencing, we performed microarray and real-time PCR analysis in 
order to confirm the CAGE sequencing data. In consistent with the CAGE sequencing, 
microarray and real-time PCR confirmed that a transcriptional switch point exists in HSPC 
ontogeny from 9.5 to 10.5 dpc at the AGM region. This work is part of the FANTOM5 
project [9-11]. Data download, genomic tools and co-published manuscripts are summarized 
at http://fantom.gsc.riken.jp/5/. 
 
Materials and Methods  
Animals 
ICR and C57BL/6J mice were purchased from Nihon SLC (Hamamatsu, Japan) and 
Kyudo (Tosu, Japan), respectively. Noon of the day of the plug was defined as 0.5 day post-
coitum (dpc).  Embryos at various developmental stages were dissected in PBS under a 
stereomicroscope and the number of somite pairs (SP) counted[13,14]. Animals were handled 
according to Guidelines for Laboratory Animals of Kyushu University. This study was 




The caudal portion of embryos containing the p-Sp/AGM region was used to obtain a 
single cell suspension. ICR embryos were used at 8.5 dpc, whereas C57BL/6J embryos were 
used at 9.5, 10.5 and 11.5 dpc. Single cells were prepared from p-Sp/AGM at 8.5 dpc and the 
AGM region at 9.5, 10.5 and 11.5 dpc by collagenase treatment (see Supplementary 
Methods). PLs at 11.5 dpc without deciduas and umbilical vessels were passed through 21-
gauge needles and incubated with collagenase. To isolate mononuclear cells, density gradient 
centrifugation using Lympholyte®-M Cell Separation Media (Cedarlane Laboratories, 
Ontario, Canada) was performed according to the manufacturer’s instructions.  
To obtain FL HSPCs, FL cells from 12.5, 14.5 and 19.5 dpc C57BL/6J embryos were 
filtered through 40-µm nylon mesh (BD Biosciences) and washed once with PBS. 
Mononuclear cells were isolated as stated above. Mature blood cells were removed by cell 






















































































































































sorting after staining with biotin-conjugated anti-lineage markers (see Supplementary 
Methods). 
To obtain adult BM HSPCs, femurs, tibias and humeri of 2 to 3-month- and 2-year-old 
C57BL/6J mice were dissected out. BM cells were harvested by flushing with PBS and 
passed through 40-µm nylon cell strainers (BD Biosciences). Mononuclear cells were 
isolated and mature blood cells removed by magnetic-activated cell sorting. Cells were 
incubated with biotin-conjugated antibody as described above. Cells were then incubated 
with anti-Biotin MicroBeads (MiltenyiBiotec, BergischGladbach, Germany) and passed 
through MACS
®
 Separation Columns (MiltenyiBiotec).  
 
Flow cytometry and cell sorting  
Antibodies used for cell sorting are shown in Supplementary Methods. After gating for 
propidium-iodide (PI)-negative (living) cells, mesodermal cells, pre-HSPCs and HSPCs were 
isolated from hematopoietic organs using the following protocol. For the 8.5 dpc p-Sp 
sample, among E-cadherin-negative non-endodermal cells, mesodermal cells expressing Flk-
1 (Vegf receptor 2) and c-Kit (stem cell factor receptor) were sorted out. For the 9.5 dpc 
AGM region sample, cells double-positive for CD31 (PECAM-1) and CD34 (mucin-like 
glycoprotein), which include both HSPCs and vascular endothelial cells, were selected. 
Among CD31+/CD34+ cells, hematopoietic cells expressing c-Kit were sorted out as pre-
HSPCs. For the 10.5 dpc AGM region, cells double-positive for CD31 and CD34, which 
include both HSPCs and vascular endothelial cells, were selected. Among CD31+/CD34+ 
cells, c-Kit+ hematopoietic cells were sorted. To remove macrophages among hematopoietic 
cells, we used glycoprotein F4/80. In addition to the AGM region, PL reportedly generates 
adult repopulating HSCs. Thus we collected a sample from PL expressing c-Kit, CD31 and 
CD34 at 11.5 dpc [15]. For 12.5 dpc FL [16], we sorted HSPCs expressing Sca1 (stem cell 
antigen 1), c-Kit and CD45. The common leukocyte marker, CD45 was used as an HSC 
maturation marker. To remove differentiated cells in 14.5 dpc FL [16], we used Ter119 
(erythroid cells), CD45 (leukocytes), CD19 (B-lymphocytes), CD4, CD8 (T-lymphocytes), 
Gr-1 (granulocytes) and F4/80 (macrophages) markers for cell sorting, and all negative cells 
were classified as lineage negative (Lin−). Among Lin−/Sca1+ cells, c-Kit+/CD45+ cells 
were sorted as HSPCs. To examine the effect of aging, BM HSPCs from 2 to 3-month-old or 
2-year-old mice were collected by selecting CD34−/Sca1+/c-Kit+ cell populations. Among 






















































































































































Lin−/Sca1+ cells in 2- to 3-month-old BM, c-Kit+ cells were sorted out, regardless of CD34 
expression.  
 
RNA extraction and CAGE analysis 
Total RNA was isolated and treated with DNase I by using an RNeasy
®
 Plus Micro Kit 
(Qiagen, Hilden, Germany) according to the manufacturer’s instruction. CAGE analysis was 
carried out as part of the Functional Annotation of the Mammalian Genome 5 (FANTOM5) 
project at the RIKEN Omics Science Center in Yokohama, Japan. 
For real-time PCR, total RNA was isolated and treated with DNase I using an 
RNAqueous®-4PCR kit (Ambion Inc., Austin, Texas), according to manufacturer’s 
instruction. DNase I-treated RNA was quantitated by NanoDrop 2000/2000c (Thermo 
Scientific, Delaware). cDNA was prepared using a High Capacity RNA-to-cDNA kit (Life 
Technologies, Carlsbad, CA) according to the manufacturer’s instruction. Briefly, the cDNA 
synthesis reaction included random octamers, dNTPs, an RNase inhibitor, MuLV reverse 
transcriptase and DNase I-treated RNA. cDNA was synthesized at 37°C for 60 min followed 
by denaturation at 95°C for 5 min and holding at 4°C until use. 
 
CAGE bioinformatics analysis 
TSSs were assigned to known genes by the FANTOM5 consortium. If the CAGE peak 
was within 500 bases of the 5’ end of a known transcript, it was annotated with the gene 
name from which that transcript was derived. Enrichment of differentially expressed genes 
with respect to transcription factor ChIP-seq datasets was calculated using the GSCA tool 
[17], while functional and pathway enrichment was calculated using Database for Annotation, 
Visualization and Integrated Discovery (DAVID) [18,19]. ChIP-sequencing data for multiple 
transcription factors in HSCs and HPCs was collected from gene expression omnibus [10,20-
22]. Enrichment for known sequence motifs was performed using HOMER [23]. Genome-
wide chromatin modifications in murine HSC samples were downloaded from Mouse 
ENCODE [19], and  methylation data was downloaded from Hogart et. al [24]. The 
SeqMINER tool was used to cluster epigenetic marks [18]. P-values were calculated using a 
hyper-geometric test. Data analysis was done using a combination of R, perl and shell scripts. 






















































































































































To provide a snapshot of global transcription (the transcriptome) in HSCs across different 
times and locations, GEDI (Gene expression dynamics inspector) plots (maps) were 




Microarray analysis of three independent samples each of AGM-derived HSPCs at 9.5 
and 10.5 dpc was performed and compared. Total RNA was isolated from sorted 
hematopoietic cells using an RNAqueous
®
 Total RNA Isolation Kit (Thermo Fisher 
Scientific Inc. MA). Total RNA was linearly amplified in two rounds of T7 in vitro 
transcription to generate antisense amplified RNA (aRNA) using a MessageAmp™ II aRNA 
Amplification Kit (Thermo Fisher Scientific Inc., MA), and an Illumina® TotalPrep RNA 
Amplification Kit (Thermo Fisher Scientific Inc., MA) according to the manufacturer’s 
instructions. During the second round of amplification, aRNA was labelled with biotin16-
UTP. aRNA was purified and verified by spectrophotometry. Subsequently, the Illumina 
Gene Expression system (Illumina, Inc., CA) was used for direct hybridization of labelled 
aRNA to gene-specific 50-mer oligonucleotide probes attached to microbeads according to 
the manufacturer’s instruction. After hybridization and washing, BeadChips were 
immobilized with Cy3-streptavidin (GE Healthcare; Buckinghamshire, UK) and scanned 
using an Illumina BeadArray Reader.  
To analyse microarray data and filter criteria, raw signal intensities of six samples were 
normalized using the quantile algorithm with ‘lumi’ [25] and the ‘preprocessCore’ library 
package [26] on Bioconductor software [27]. Probes called by the ‘Detection p-value < 0.05’ 
flag in at least one sample were selected. Then, Linear Models for Microarray Analysis 
(limma) package [28] of Bioconductor software was applied. Differentially expressed genes 
were shown on a heat map generated by MeV software [29]. Hierarchical clustering (HCL) 
analysis was used to sort genes. Color coding indicated distance from the median of each row. 
DAVID was used to investigate gene ontology (GO) categories enriched for function of 
differentially expressed genes. Genes encoding factors functioning in transcription, either up-
regulated or down-regulated, were selected and validated by real-time PCR.  Primer sets used 
are shown in Supplementary Table S1. 
 






















































































































































Real-Time PCR analysis 
Gene expression levels were measured by real-time PCR using Fast SYBR® Green 
Master Mix (Life Technologies, Carlsbad, CA) and StepOnePlus
TM
 real-time PCR (Life 
Technologies, Carlsbad, CA). Forward and reverse primers were designed using 
PrimerExpress® version 3 (Applied Biosystems) and are listed in Supplementary Table S1. 
Primer specificity was assessed in silico using BLAST (Supplementary Table S1). Primer 
efficiency was calculated from the slope of the calibration curve using five-fold serial 
dilution of cDNA prepared from whole embryos or whole fetal organ-derived cDNA in real-
time PCR. Amplification conditions were an initial denaturation at 95°C for 20 sec, followed 
by 40 cycles of denaturation at 95°C for 3 sec and annealing and extension at 60°C for 30 sec. 
To ensure specific amplification, melting curve analysis was evaluated in all analyses and in 
a negative control lacking cDNA template. Melting curve analysis consisted of denaturation 
at 95°C for 15 sec and annealing at 60°C for 1 min/cycle, and annealing temperature was 
increased 0.3°C/cycle until 95°C.All analyses were performed in triplicate wells; mRNA 
levels were normalized to Actb mRNA, and the relative quantity (RQ) of expression was 
calculated by delta delta Ct method and compared with a reference sample. Differences were 




Collection of HSPC samples from murine tissues at different developmental stages  
To characterize changes in the HSPC transcriptome during hematopoietic development, 
we collected 10 samples from diverse murine organs at selected developmental time points 
(Fig. 1A). Relevant to marker analysis, E-cadherin− Flk-1+ cells represent mesodermal cells 
[30], and c-Kit marks intra-aortic clusters of the AGM region [13] [31]. Hematopoietic 
multipotent progenitors in the p-Sp region at 8.0 dpc [32] and Flk-1+ c-Kit+ cells have been 
observed at p-Sp/ AGM region at 9.5 dpc [33]. Therefore, we collected E-cadherin–/Flk-1+/c-
Kit+ mesodermal cells, the ancestors of hematopoietic cells, from the caudal region (p-Sp) of 
8.5 dpc embryos. Cells capable of reconstituting neonatal recipients, known as “pre-HSPCs”, 
have been detected in the p-Sp/AGM region at 9.5dpc [34,35], while cells present at 10.5-
11.5 dpc acquire the capacity to reconstitute adult recipients and are known “long term-






















































































































































repopulating HSCs” [36-38]. We obtained both pre-HSPC and HSPC samples from the AGM 
region by selecting cells expressing the HSPC marker c-Kit and the endothelial markers 
CD31 and CD34 [39,40]. 
Among the 10 HSPC populations identified, we observed that HSPCs form a very small 
proportion of cells from a given niche (Fig. 1B). For the 8.5 dpc p-Sp sample, E-
cadherin−/Flk-1+/c-Kit+ cells represented 2.5±0.18% of the population; for the 9.5 dpc AGM 
region, CD31+/CD34+/c-Kit+ cells represented 0.68±0.32%; and for 10.5 and 11.5 dpc 
AGM samples, CD31+/CD34+/c-Kit+/F4/80− cells represented 0.12±0.08% and 
0.09±0.14%, respectively. For 11.5 dpc PL, CD31+/CD34+/c-Kit+/F4/80− cells represented 
0.79±0.67%; for 12.5 dpc FL, Sca-1+/c-Kit+/CD45+ cells represented 0.75±0.12%; and for 
14.5 and 19.5 dpc FL, Lin−/Sca-1+/c-Kit+/CD45+ cells represented 6.57±0.95% and 
3.95±1.0%, respectively. Finally, for 2 to 3-month-old and 2-year-old BM, Lin−/Sca-1+/c-
Kit+ cells represented 0.044±0.009% and 0.14±0.09%, respectively. Surface markers used to 
sort each sample are shown in Fig. 2A. 
 
CAGE profiling of murine HSPCs identifies stage-specific transcripts 
To study genome-wide transcriptional dynamics during HSPC development, we 
performed single molecule CAGE [12] sequencing of the 10 samples identified. The rarity of 
HSPCs during early development represents a challenge requiring collection of large 
numbers of mouse embryos. Thus, we opted not to generate replicates for each population. 
By generating approximately 250,000 reads per sample, we identified a total of 15,681 
distinct TSSs, which were detected (>=10 tags per million) in at least one of 10 samples, with 
an average of 8,037 TSSs per sample. We then employed GEDI plots [41] to provide a 
global gene expression overview of each sample. GEDI plot analysis revealed a distinct 
transcriptome signature in each of the 10 samples (Fig. 2A). More than 3,000 TSSs showed at 
least a two-fold difference in expression among p-Sp-8.5 dpc-derived mesoderm, AGM-9.5 
dpc-derived pre-HSPCs, and AGM-10.5 dpc-derived HSPC samples, whereas approximately 
1,000 TSSs were differentially expressed in HSPCs derived from AGM-11.5 dpc, PL-11.5 
dpc, FL-12.5 dpc, FL-14.5 dpc, FL-19.5 dpc, 2 to 3-month-old BM, and 2-year-old BM (Fig. 






















































































































































2B). These observations suggest that major transcriptional changes likely occur in the AGM 
region between 9.5 and 10.5dpc. 
Of TSSs, 15,681 were within 500 bases of a known transcript and were thus annotated 
with the corresponding gene symbol (representing 10,385 separate genes). The remaining 
1,681 TSSs were unannotated and may represent novel HSPC-specific transcripts. The ratio 
of TSSs to genes was greater for transcription factors (TFs), with 1,518 TSSs mapping to 880 
transcription factors (ratio 1.7 compared to 1.5 for all genes), suggesting that alternate 
transcription of TFs contributes to the regulatory complexity of the mammalian genome [42]. 
To validate this data using an independent source, we collected ChIP sequencing data for 
five chromatin modifications (H3K27me3, H3K4me3, H3K4me1, H3K79me2 and 
H3K27Ac) and for CTCF (CCCTC-binding factor) binding in murine HSCs derived from 
bone marrow [43]. Over the 15,681 TSSs flanking known transcripts, H3K4me3 and 
H3K79me2 (predictors of transcription initiation) were enriched near CAGE peaks, while 
H3K4me1, an enhancer signature, and H3K27me3, a signature of inactive promoters, were 
depleted, supporting the idea that our analysis detects active transcription initiation events 
(Fig. 2C). All TSSs also overlapped with binding of CTCF binding, which reportedly 
preferentially binds near promoters [44]. 
Finally, to confirm the identity of each sample we checked expression profiles of genes 
encoding HSPC surface markers (Flk-1, c-Kit, CD31, CD34 and Sca-1) and lineage markers 
(E-cadherin, F4/80, Gr-1, CD4, CD8, Ter119 and CD19) used for cell sorting 
(Supplementary Fig. S1A). As expected, we detected high CD34 levels in all samples. Flk-1 
was detected only in AGM samples and was down-regulated in PL, FL and BM-derived 
populations. Similarly, Pecam1 (also known as CD31) was expressed at low levels in non-
AGM samples. Conversely c-Kit, Sca-1 and Ptprc (also known as CD45) were more highly 
expressed in PL, FL and BM-derived populations relative to AGM. We also detected low 
levels of Prom1 (also known as CD133), a marker of some early HSPC populations [45], in 
mesodermal and pre-HSPC samples. 
 
A transcriptional switch point in HSPC ontogeny occurs in AGM between 9.5and 10.5 dpc 
Hierarchical clustering of the 10 HSPC populations assigned them to four clusters:1) pre-
HSPCs (p-Sp/8.5 dpc and AGM/9.5 dpc), 2) early HSPCs (AGM/10.5 dpc, AGM/11.5 dpc, 






















































































































































PL/11.5 dpc and FL/12.5 dpc), 3) fetal definitive HSPCs (FL/14.5 dpc and FL/19.5 dpc), and 
4) adult definitive HSPCs (BM in 2 to 3-month-old mice and BM in 2-year-old mice) (Fig. 
3A). Principal component analysis of the 10 samples was in agreement with partitioning of 
populations into four corresponding groups (Fig. 3B). In short, this analysis suggests that 
HSPCs are committed in group 1, become mature and prepared to move to FL in group 2, 
proliferate, differentiate into mature hematopoietic cells and prepare to move to BM in group 
3, and settle in BM and become quiescent in group 4.  
 To understand differences between groups we identified sets of differentially expressed 
genes and annotated them using functional and pathway enrichment analysis (Fig. 3C). 
Although 9.5 and 10.5 dpc HSPCs exhibit similar surface markers, they were clustered into 
pre-HSPCs and early HSPCs, respectively, based on global gene expression patterns. 
Consistent with this clustering, the transition from endothelial to HSPC phenotype occurs 
after 9.5 dpc [13]. Therefore, genes related to vascular development are more highly 
expressed in group 1 (pre-HSPCs) than in group 2 (early HSPCs) (Fig. 3C). In addition, intra-
aortic clusters containing embryonic HSPCs in the AGM region at 9.0-10.5 dpc are likely 
released into circulation in order to home to FL at 10.5-11.5 dpc based on 1-integrin 
expression [46,47]. We observed up-regulation of genes functioning in trans-endothelial 
migration in early rather than pre-HSPCs (Fig. 3C; see“2 versus 1_up”), implying that early 
HSPCs are prepared to home. Hematopoietic genes were up-regulated in HSPCs in groups 
2,3,4, suggesting that group 1 pre-HSPCs are not yet committed to an adult HSPC program. 
Accordingly, Pecam1 and Cdh5 (also known as VE-cadherin) were down-regulated in groups 
2, 3, and 4 relative to group 1, whereas Itga2b (also known as CD41) was up-regulated in 
those groups, as expected. Two key regulators, Ccnd1 (cyclin D1) and Twist1, were down-
regulated in groups 2,3 and 4 relative to group 1. Twist1 down-regulation suggests that it 
may act as a master regulator of HSPC generation, while Ccnd1down-regulation suggests that 
proliferative status of group 1 pre-HSPCs changes as development proceeds (Supplementary 
Fig. S1B). 
 
Identification of transcription factors regulating HSPC ontogeny  
To identify stage-specific TFs governing HSPC development and maturation, we 
randomly selected 43 TFs differentially expressed (based on at least a two-fold expression 
change) among the 10 samples (Fig. 4A). Of these, 9 (Sox18, Hmga2, Sox17, Sox7, Peg3, 






















































































































































Hey1, Sox11, Snai1 and Fhl2) were down-regulated during HSPC maturation (Fig. 4A, blue 
box). Expression of Sox17, Sox18 and Sox7 in AGM/9.5 dpc-derived pre-HSPCs suggests 
that these cells represent either endothelial/hematopoietic cell progenitors or cells in a 
transition state [13,48]. About a third (11 of 43) of the TFs (Hes6, Nr2c2, Tob1, Arhgap17, 
Irf1, Runx1, Cebpa, Nrip1, Maz, Mta1 and Aes) (Fig. 4A, red boxes) was differentially 
expressed between AGM-9.5 dpc and AGM-10.5 dpc. 
We reasoned that dynamically expressed gene loci should be enriched for cis-regulatory 
motifs recognized by these TFs. Most enriched cis-regulatory motifs for known factors 
obtained using HOMER software [23] (Fig. 4B) were over-represented relative to random 
background sequences with the same GC content across all samples. They included motifs 
recognized by key HSPC TFs including ETS, bHLH proteins, JUN, MYB, PU.1 and STAT 
proteins. The Gfi1b motif was enriched in 11.5 dpc PL but with p-value <1e-3, which was 
lower than the strict cutoff (p = 1e-5). Three motifs, the ISRE (IFN-stimulated response 
element) [49] and sequences recognized by Cebp and Runx1, showed progressively greater 
enrichment during HSPC ontogeny (Fig. 4B). The ISRE motif is found in promoters of genes 
induced by interferon, which activates dormant HSCs [50]. Moreover, Ifnar2, a target of INF 
alpha, was up-regulated in both FL and BM samples (Supplementary Fig. S1B). 
 
Microarray analysis and gene selection and validation 
To identify transcription factors that differentially expressed in AGM-derived HSPCs at 
9.5 and 10.5 dpc tissues, we selected a total of 370 differentially expressed genes after 
statistical analysis with limma (Supplementary Table S2). A heat map of these genes is 
shown (Fig. 5A). We then conducted enrichment analysis of gene function (Enrichment score 
> 1.3) of 370 genes. Among them (Supplementary Table S2), 257 genes matched with gene 
identifier of the DAVID, and seven annotation clusters were enriched (Fig. 5B). We selected 
40 genes for real-time PCR analysis, and that those genes are shown in Table 1. These 40 
genes were normalized intensities based on three independent samples and consisted of 20 
up- and 20 down-regulated genes whose sequence information was obtained through the 
NCBI website and for which primer sets could be designed for real-time PCR. Then real-time 
PCR analysis was conducted to analyse gene expression in AGM-derived HSPC at 9.5 and 
10.5 dpc. Among 20 up-regulated genes, 11 were significantly up-regulated (P< 0.05) at 10.5 






















































































































































dpc relative to 9.5 dpc (Fig. 5C). Among 20 down-regulated genes, 12 were significantly 
down-regulated (p < 0.05) at 10.5dpc relative to 9.5 dpc (Fig. 5D).  
 
Discussion 
Genome-wide datasets have been generated to address how transcriptional networks 
govern numerous biological processes. Though microarray-based expression profiling is 
widely used for this purpose, the standard array does not provide information relevant to 
transcript levels. We therefore used CAGE to construct a global picture of the transcriptional 
landscape regulating HSPC development, including transcript levels. The CAGE shows that a 
transcriptional switch point occurs between 9.5 and 10.5 dpc in the AGM region. 
Due to the rarity of HSPC samples, we could not generate replicates in CAGE. Based on 
this outcome, in analysing rare samples, CAGE sequencing could be used for screening 
purposes to predict stage-specific transcripts, while microarray analysis could be useful for 
statistical evaluation regardless of TSSs.  
Others have reported bias in the non-specific guanine at the 5’ end of the CAGE tag [51]. 
However, such bias is unlikely to underlie the large number of novel unannotated TSSs in 
HSPCs. First, FANTOM5 CAGE tags are longer, which can multimap and more stringent 
mapping procedure. In addition, the heliscope CAGE protocol does not use PCR, so tags are 
not amplified. In FANTOM5, the heliscope CAGE protocol generates a much longer CAGE 
tag (~32 bases or longer) rather than 18-21 bases in FANTOM3, allowing unequivocal 
unique mapping of most tags. Also, in FANTOM5 a more advanced probabilistic aligner 
known as Delve is used and only reports uniquely-mapping tags.  
We collected 10 developmental murine HSPC populations isolated from the AGM 
region, PL, FL and BM. Principal component analysis of TSSs defined 4 HSPC groups 
among 10 samples (Fig. 3). Previously, Daley’s group reported microarray analysis of gene 
expression during HSC ontogeny [52]. They collected embryonic and adult HSC samples 
from different stages and sites, in addition to ES cell-derived HSCs. Both of our studies 
demonstrate that HSPC specification occurs from 10.5 to 12.5 dpc, regardless of cellular 
location. Their study used CD150 as an HSC marker in FL and BM; thus clustering 
differences between our groups are likely due to cell surface phenotypes used for cell 
collection. In addition, they evaluated a 9.5 dpc yolk sac sample, whereas we assessed both 
8.5 dpc mesoderm and 9.5 dpc AGM samples. Both of our studies suggest that that dynamic 
gene expression changes occur in HSPCs from 9.5 to 10.5 or 11.5 dpc, as the transition from 






















































































































































endothelial to hematopoietic HSPC phenotypes occurs [13,37], implying that HSPC 
commitment is programmed by this time point. Based on this data, it is likely that a major 
transcriptional switch occurs from 9.5 to 10.5 dpc.  
To confirm this transcriptional switch, we performed microarray analysis using triplicate 
samples. Clustering analysis identifying changes in cytoskeletal genes suggests a transition 
from endothelial to hematopoietic HSPCs, an outcome consistent with prediction of CAGE 
sequencing and phenotypic changes observed in HSPCs [13]. Based on ratios, p-values and 
adjusted p-values, we chose 40 differentially expressed genes to validate by real-time PCR. 
Among them, 23 were significantly altered (either up-regulated or down-regulated), 
demonstrating of the utility of the dataset. The function of some of these genes remains 
unclear in hematopoiesis. 
Overall, the dataset presented here should foster identification of novel genes involved in 
HSPC development and further our understanding of HSPC biology. Our work could also 
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FIG. 1. Isolation of hematopoietic stem and progenitor cells from mouse embryos and adults. 
(A) A total 10 tissues (indicated in red) derived from 9 indicated developmental time points 






















































































































































served as HSPC sources for CAGE analysis. They include:1) caudal regions (p-Sp, dotted 
line) of 8.5 dpc embryos  (mesoderm); 2) 9.5 dpc p-Sp/AGM tissue for pre-HSPCs; 3) AGM 
tissue at 10.5 dpc and 4) 11.5 dpc; 5) 11.5 dpc placenta (PL); 6) 12.5 dpc fetal liver (FL); 7) 
14.5 dpc FL; 8) 19.5 dpc FL; 9) BM from 2 to 3-month (mo)-old mice; and 10) BM from 2-
year (yr)-old mice. (B) Flow cytometric analysis of hematopoietic tissues based on surface 
expression of hematopoietic cell markers. Single cell suspensions of indicated embryonic and 
adult tissues were prepared and analysed by flow cytometry. Isotype control is not shown. To 
obtain mesodermal cells at 8.5 dpc, E-cadherin-negative cells were gated first. Then among 
them, Flk-1+ and c-Kit+ cells were analysed. To obtain pre-HSPCs from p-Sp/AGM tissue at 
9.5 dpc and HSPCs from AGM tissue at 10.5 dpc and from placenta at 11.5 dpc, CD31+ and 
CD34+ cells were gated first. Then c-Kit+/F4-80− cells were analysed on CD31+/CD34+ 
cells. To obtain HSPCs from PL at 11.5 dpc, CD31+ and CD34+ cells were gated first. Then 
among them, c-Kit+ cells were analysed. To obtain HSPCs from FL at 12.5 dpc, Sca-1+/c-
Kit+ cells were gated first and then CD45+ cells were analysed among them. To obtain 
HSPCs from FL at 14.5 and 16.5 dpc, Lin− and Sca-1+ cells were gated first. Then c-
Kit+/CD45+ cells were analysed among them. To obtain HSPCs from BM at 2 to 3-month- 
and 2 year-old mice, Lin− and Sca-1+ cells were gated first. Then among them, c-
Kit+/CD34− cells were analysed.  
 
  
























































































































































FIG. 2. CAGE analysis over HSPC development. (A) Table showing indicated groups 
depicted in Fig. 1A, with respect to surface phenotypes, number of cells isolated, number of 






















































































































































mapped reads, TSSs identified and total number of genes mapped to for each CAGE sample, 
as well as GEDI plots of the global transcriptional landscape. Each pixel within a GEDI plot 
represents a mini-cluster of genes with similar expression pattern across all analysed samples.  
Pixel color indicates gene expression level for each cluster (blue to red indicates low to high 
levels, respectively). CAGE libraries were generated and sequenced to an average depth of 
approximately 250 thousand reads for each sample. Analysis detected use of 15,681 distinct 
TSSs in 10 samples with an average of ten thousand TSSs in each. (B) Number of 
differentially expressed TSSs between two consecutive stages of HSPC development. Given 
at least a two-fold difference transcript expression, >3,000 TSSs were differentially expressed 
between p-Sp-8.5 dpc-derived mesoderm, AGM-9.5 dpc-derived pre-HSPCs and AGM-10.5 
dpc-derived HSPCs, whereas ~1,000 TSSs were differentially expressed when comparing 
AGM-11.5 dpc-, PL-11.5 dpc-, FL-12.5 dpc-, FL-14.5 dpc-, FL-19.5 dpc-, BM-2-to 3-mo, 
and BM-2 yr-derived HSPCs. (C) 15,681 TSSs from all samples were validated using 
previously published ChIP-sequence data of chromatin modification relevant to HSPCs 
derived from bone marrow [53]. High levels of H3K4me3 and H3K27ac and lack of 




























































































































































FIG. 3. Identification of gene signatures indicative of HSPC development. (A) Hierarchical 
clustering of 10 CAGE samples. (B) Principal Component Analysis of 10 CAGE samples 






















































































































































showing indicated groups. (C) Summary of genes differentially expressed among the four 
stages, with respective gene ontology (GO) as well as pathway enrichment analysis. 
 
  
























































































































































FIG. 4. Changes in global transcription over the course of HSPC ontogeny. (A) Heat map 
showing dynamically expressed transcription factors (TFs) with their TSS location over 






















































































































































HSPC development indicating differential TF expression in the AGM between 8.5and 9.5 
dpc. Blue box indicates genes down-regulated during HSPC maturation; red boxes indicate 
up-regulated genes, including Hes6, Nr2c2, Tob1, Arhgap17, Irf1, Runx1, Cebpa, Nrip1, 
Maz, Mta1 and Aes. (B) Over-represented sequence motifs (black boxes) in each sample. 
Specifically, ISRE, CEBP and Runx1 show dynamic behaviour that reflects a particular 
pattern during HSPC ontogeny.  
 
  
























































































































































FIG. 5. Microarray analysis of AGM-derived HSPCs at 9.5 dpc and 10.5 dpc. Three 
independent samples of the AGM-derived HSPCs at 9.5 dpc and 10.5 dpc were compared. 






















































































































































(A) Heat map of 370 differentially expressed genes. (B) Function enriched (Enrichment 
Score > 1.3), as indicated by DAVID analysis. Functions of the 257 of 370 genes were 
annotated into seven clusters: cytoskeleton, intracellular organelle lumen, diacylglycerol 
binding, lysosome, GTPase regulator activity, mitochondrial lumen and phagocytosis related 
genes. Based on three independent analyses, genes encoding factors related to transcription 
(either up-regulated or down-regulated) were selected and validated by real-time PCR.  A 
total of 20 each of up-regulated and down-regulated genes from the microarray were selected 
and validated by real-time PCR. (C) Among up-regulated genes, 11 of 20 showed significant 
changes (p < 0.05) at 10.5 dpc relative to 9.5 dpc in independent samples. (D) Among down-
regulated genes, 12 of 20 showed significant changes (p < 0.05) in the same period in 
independent samples. Unfilled and grey filled bars represent gene expression levels in AGM-
derived HSPCs at 9.5 dpc and 10.5 dpc, respectively. Actb served as internal control. 
 
  






















































































































































Table1: Differentially-expressed candidate genes. 
Forty genes were selected for microarray validation. Shown are normalized intensities in both 9.5 dpc and 10.5 dpc AGM-derived HSCs (n = 3), ratios (non-
log fold-change), p-values and adjusted p-values. Up- and down-regulated genes (20 each) sorted by ratio are shown. Mpo and Mest genes, each ranked by 
three probes, were counted as one gene.  
 
Probe ID Symbol 
AGM-derived HSCs at 9.5 dpc AGM-derived HSCs at 10.5 dpc 
Ratio p-value 
Adjusted 
p-value Sample#1 Sample#2 Sample#3 Sample#1 Sample#2 Sample#3 
2970324 Hdc 830.25 935.83 231.57 9519.32 9364.16 7794.57 15.68899 0.00014 0.07378 
4880386 Muc13 291.20 293.79 650.28 3445.93 2988.55 2794.07 8.02708 0.00005 0.06115 
5720609 Lyz 355.62 371.78 610.36 1701.37 2622.91 2588.35 5.23103 0.00007 0.06715 
150458 Trp53rk 458.18 409.77 277.21 1917.66 2082.78 1026.80 4.28718 0.00041 0.08299 
6200719 Acss1 410.76 446.32 252.09 1630.10 1529.18 1126.99 3.93188 0.00018 0.07378 
4540564 Dok2 261.14 265.47 342.33 1220.66 1229.69 881.23 3.81983 0.00003 0.06115 
130634 Ddit4 568.31 588.80 1092.67 3363.15 2332.50 2439.05 3.74040 0.00042 0.08299 
6580021 Mpo 3535.14 3506.52 3883.81 9975.33 12586.18 17879.26 3.59923 0.00010 0.07378 
2940681 Gata2 3451.52 3246.33 4606.56 16151.05 8857.75 13501.76 3.34486 0.00035 0.08299 
4060593 Vangl2 450.57 481.80 579.40 1761.05 1908.88 1337.61 3.29427 0.00005 0.06115 
1450333 Clec7a 246.66 231.57 251.49 753.09 821.82 648.83 3.03497 0.00002 0.06115 






















































































































































940541 Fcrls 423.85 433.03 326.64 1168.86 1097.15 1270.86 3.00681 0.00004 0.06115 
6590167 Fcgrt 405.36 404.52 274.40 1159.82 1011.28 975.14 2.94030 0.00013 0.07378 
940309 Mpo 11146.78 10513.86 11450.52 31002.28 29213.21 31831.42 2.77991 0.00001 0.06115 
1010196 Zfp341 303.61 315.71 246.30 806.63 856.22 719.41 2.76093 0.00005 0.06115 
5860154 Lst1 643.90 674.92 767.84 1547.38 2280.48 1888.36 2.71304 0.00013 0.07378 
2140221 Slc40a1 306.05 313.44 303.61 756.40 692.31 1107.46 2.71045 0.00023 0.07845 
6280168 Mpo 526.28 528.24 452.79 1190.50 1189.41 1168.86 2.36025 0.00005 0.06115 
110717 AI428936 333.19 363.03 302.05 815.43 884.37 656.69 2.34904 0.00020 0.07472 




241.20 253.50 239.45 461.90 569.42 529.51 2.12 0.00016 0.07378 
1090180 Arhgdib 1187.16 1255.51 1424.35 2509.13 2708.39 2936.27 2.11038 0.00019 0.07378 
6660707 Klhl5 529.25 557.07 523.35 332.03 242.45 239.44 0.49989 0.00079 0.08614 
5270452 Tiam1 3596.56 3369.53 2392.86 1724.77 1283.19 1530.37 0.48882 0.00194 0.10631 
1500768 Dcbld1 881.68 921.93 710.39 342.22 462.24 422.83 0.48747 0.00086 0.08804 
1820224 Marcks 1643.34 1516.90 1400.90 690.10 769.78 743.61 0.48363 0.00016 0.07378 
4880554 Cnih4 2341.05 2386.38 1591.44 872.82 975.52 1036.81 0.46306 0.00098 0.09054 
6940068 X99384 1487.66 1339.79 1286.74 755.13 501.51 657.07 0.45951 0.00066 0.08413 
 
 






















































































































































450372 Bok 2243.17 1962.47 2329.19 842.41 945.04 1235.39 0.45776 0.00060 0.08413 
6330445 Mogat2 698.27 716.26 772.59 307.48 344.58 344.01 0.45521 0.00008 0.07262 
3190408 Mest 2336.51 2268.08 2692.25 814.69 1242.20 1239.92 0.44471 0.00091 0.09005 
3440343 Cap1 952.25 998.10 550.70 310.26 330.02 393.64 0.42545 0.00225 0.11264 
6350044 Slc2a1 7385.06 7320.20 4586.46 2559.53 2795.69 2645.31 0.42422 0.00083 0.08659 








4395.28 4543.87 5979.14 2324.44 2188.63 1465.30 0.40 0.00077 0.08610 
6770356 Mest 7257.15 6954.87 7505.60 2006.52 2951.52 3837.83 0.39148 0.00100 0.09078 
6290133 Endod1 1245.66 1289.43 950.12 398.92 462.24 488.60 0.38938 0.00015 0.07378 
1690019 Mest 6712.69 6420.07 6332.16 1794.83 2574.71 3281.06 0.38159 0.00063 0.08413 
2480059 Anxa5 1860.18 1826.27 1097.72 649.96 544.17 558.57 0.37557 0.00065 0.08413 
2690435 Peg3 9670.34 9364.16 5634.74 2278.11 2916.39 3233.71 0.34789 0.00069 0.08413 
160519 Tmem65 2148.18 2243.17 1723.06 640.14 658.88 770.88 0.33958 0.00004 0.06115 
610092 Grm6 1041.87 1021.59 538.14 234.23 245.66 386.25 0.33855 0.00213 0.10902 
4060521 Xist 2281.13 2399.39 1088.77 471.60 543.83 684.85 0.30890 0.00157 0.10062 
 

















































































































































































































































































































Somite pairs (SPs) were counted as a means to stage embryos, as follows [1,2]: 8.5 dpc (5-8 SP), 9.5 dpc (18–22 SP), 10.5 dpc (32-34 SP), and 
11.5 dpc (42-46 SP). 
Cell preparation 
Single cell suspensions were prepared as described with small modifications [2-6]. Tissues representing p-Sp/AGM at 8.5 dpc and the AGM at 
9.5, 10.5 and 11.5 dpc were incubated with 1 mg/mL collagenase (Washington Biochem Co., Freehold, New Jersey) in alpha-MEM 
supplemented with 10% fetal bovine serum for 30 minutes at 37°C, filtered through 40-µm nylon cell strainers (BD Biosciences, San Diego, 
CA), and washed once in PBS. For 11.5 dpc placenta, placentas without deciduas and umbilical vessels were passed through 21-gauge needles 
and incubated with 1 mg/mL.  
To obtain fetal liver HSPCs at 12.5, 14.5 and 19.5 dpc, mature blood cells were removed. First, mononuclear cells were stained with the 
following biotin-conjugated antibodies that bind to lineage surface markers of mature blood cells: biotin anti-mouse Ter119 for mature 
erythrocytes, biotin anti-mouse Ly-6G/Ly-6c (Gr-1) for granulocytes, biotin anti-mouse F4/80 for macrophages, biotin anti-mouse CD45R/B220 
for B lymphocytes, and biotin anti-mouse CD4 and biotin anti-mouse CD8 for T lymphocytes. All antibodies were from BioLegend, San Diego, 
CA. After washing once in PBS, cells were stained with Streptavidin eFluor
®
 450 (eBioscience, San Diego, CA).  
 
 






















































































































































Antibodies for flow cytometry and cell sorting 
Antibodies used for cell sorting were: PE-conjugated anti-mouse E-cadherin (R&D Systems, Minneapolis, MN), Alexa Fluor 647 anti-mouse 
Flk-1 (VEGFR2), APC- and PE-Cy7-conjugated anti-mouse CD117 (c-Kit), Alexa Fluor 488 anti-mouse CD31, PE-conjugated anti-mouse 
CD34 (eBioscience), PE-Cy7-conjugated anti-mouse F4/80, PE-conjugated anti-mouse Ly-6A/E (Sca-1), PE-Cy7-conjugated anti-mouse CD45, 
and FITC-conjugated anti-mouse CD34 (eBioscience). Unless otherwise noted, antibodies were from BioLegend. Flow cytometric analysis and 
cell sorting were carried out using a FACSAria SORP cell sorter (BDIS, San Jose, CA). Data files were analyzed using FlowJo software (Tree 
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Muc13 Forward: GGAGAAATGGGCAGAGACAAAG  
Reverse: TTCGGCAAGCTTCGGTCTT 
NM_010739.1 100 
Dok2 Forward: CCCACCCTCCTCCTACACTTT 
Reverse: GACATCTGTGGAAACCCTTTGTC 
NM_010071.2 100 
Vangl2 Forward: CGGTGACCAATGGGCTTAAG 
Reverse: GAGAGTTTGAAGAAGGGCACCTT 
NM_033509.3 100 




Fcrls Forward: TGTGGCGGAGCTTCACTGT 
Reverse: AAAAGGTGCCGAGGTGTTAGC 
NM_030707.3 100 
Mpo Forward: AACCCAGGCGTGTTCAGTAAA 
Reverse: TCTTCGACACGGTGGTGATG 
NM_010824.1 100 
Zfp341 Forward: AGCCAGCCCTTGCTTCAGAT 
Reverse: GTGCTATACGAAGTCCTGTTGCA 
NM_199304.1 100 
Tmem65 Forward: GCACCGCTTCGAGTCCAT 
Reverse: AGGTATCGCATTGTGGAAGAATACA 
NM_175212.4 103 
Lyz Forward: CTGCCCCTTTCATCTTGCTT 
Reverse: CCTCCTGAATGCCTCATGACA 
NM_013590.2 101 
3110004L20Rik Forward: TCGCTAAGTTCTCCTTACTGGTT   
Reverse: GTGGAAAACAGCAGCACAGG 
NM_001033167.1 101 
Mogat2 Forward: GTCTGCCCTGGCACCTACTC 
Reverse: AGTGACCCCTGCCCTCCTTA 
NM_177448.3 102 
Hdc Forward: CAGGGTCTTCGTGATCCACAA 
Reverse: CACCGTCTCAGCCCCTTCTA 
NM_008230.4 100 






















































































































































Acss1 Forward: GGTGGAGCTGAAGAAAATAGTGGAT 
Reverse: CCCCATGGGAACCTTGGT 
NM_080575.1 100 
Fcgrt Forward: CCTCAAGACCCTGGAGAAGA 
Reverse: CCGTGGGCACTGAGGAATTA 
NM_010189 96 
Lst1 Forward: ATCTGCTTGTGCCGGTTCAG 
Reverse: CTGGCAGCTGCTGGAGAGA 
XM_359281.1 100 
Emp3 Forward: GCTTTTTGTGGCCACTTTGG 
Reverse: TGTTTGAGTGGTGGTGTTCCA 
NM_010129.1 100 
5830436K05Rik Forward: ACATTCGAAGGAACCTGGCT 
Reverse: AATCCTGCAGCACAAACAGC 
XM_488874 99 
Arhgdib Forward: TTCTCCCACCTTGAGTCCTGAA 
Reverse: GGAAGAACCCAGTGGCAAGA 
NM_007486.1 101 
Marcks Forward: GTCTCCACCCTGCCCATTT 
Reverse: AACAGTAACCATTCCACGTATCACA 
NM_008538.2 102 
Bex2 Forward: TGGAGAAGCTGAGGGAAAGG 
Reverse: CAGGGCATAAGGCAAAACTCAT 
XM_977338.1 100 
Endod1 Forward: GCTAATGGAAGCCAGTCATGGT 
Reverse: AGCCTGTCGTCTTGATGGTGAT 
NM_028013.2 100 
AI428936 Forward: TGGCCACCGGAAACATTTAG 
Reverse: CAGCATTGCATCAGGCAGACT 
NM_153577.2 100 
Slc40a1 Forward: GCCTTAAGGGCTAGGAGCAC 
Reverse: GACTGCCTCTCCCTCTTCCT 
NM_011400.2 98 
Bok Forward: GAGAAGCCAGGGATGCAGAGT 
Reverse: TGGTTCCTGCCATGAAGGA 
NM_016778 100 
Mest Forward: CCTCCCCCATTCTCGTATCTG 
Reverse: GTGAAGGAAATGGACTTTGATGAA 
NM_008590.1 100 
Anxa5 Forward: GATTTGATGGCAGGGCTGAT 
Reverse: TTGCTTCGGGATGTCAACAG 
NM_009673.1 100 
Peg3 Forward: CCCCTTGAGACTGATTGTGTAACC 
Reverse: TTTGCAAGAAAACCACTGTAAGGTA 
NM_008817.2 106 
7530408C15Rik Forward: CGATCCTGGGACAAACACTTG 
Reverse: TCCAACTACGTACAGTAGCCCATTC 
NM_001195075.1 100 
Klhl5 Forward: TTTCATGGAAGTAATCAGGAACCA 
Reverse: CTCCTCGTTCGGGATGTTCA 
NM_175174.2 100 
Slc2a1 Forward: ACCTCTTCCGAACCGACAGA 
Reverse: TGGAGCCATCAAAGTCCTGAA 
NM_011400.2 100 
Dcbld1 Forward: CGGCCATGACTGCTCTTTTG 
Reverse: ACATGCACGCTTGCACATTT 
NM_025705.2 103 






















































































































































Trp53rk Forward: GGTGTCTTAAGAGGGCACCA 
Reverse: GCCTTTCCACAGGACCAGAG 
NM_023815.4 101 
Ddit4 Forward: AGGTTGTATGCAGGTGGCTC 
Reverse: TACACATCCAGCCAGAAGCC 
NM_029083.1 100 
Gata2 Forward; CACCCCTATCCCGTGAATCC 
Reverse: AGGGCTCAGCAGTAGAGAGT 
NM_008090.4 100 
Cnih4 Forward: GTGCTGATGCTTGTCTCCCT 
Reverse: GTTGCCACTTGGCACCATAA 
NM_030131.2 100 
Xist Forward: AAAACGGGAAGAGGCCAGAG 
Reverse: GTGTTCTGCATGCTTGGTCC 
NR_001463.2 101 
Tiam1 Forward: GGAAGGCTACAGCTTCCTGA 
Reverse: CCACAATGGTTCTACCCGCT 
NM_009384.2 100 
Grm6 Forward: AGAGTCCTCCCTTGGTGTGT 
Reverse: CAGAAGCCTCAGTCCAGAGC 
NM_173372.1 98 
Cap1 Forward: CGCCTCCTCCCCCAATTC 
Reverse: TGTGTGATGCTTTCCCCCTG 
NM_007598.2 97 


























































































































































Supplementary Table S2: List of 370 differentially expressed genes by microarray analysis. 





AGM-derived HSC at 9.5 dpc AGM-derived HSC at 10.5 dpc 
ratio p-value Adjusted p-
value Sample#1 Sample#2 Sample#3 Sample#1 Sample#2 Sample#3 
2970324 Hdc 830.25 935.83 231.57 9519.32 9364.16 7794.57 15.69 0.00014 0.07378 
4880386 Muc13 291.20 293.79 650.28 3445.93 2988.55 2794.07 8.03 0.00005 0.06115 
6550500 Slc41a3 220.98 223.15 339.68 3891.32 1252.49 669.85 5.80 0.00448 0.12896 
5890719 Fam110b 365.57 389.56 281.13 3673.80 1807.58 1157.27 5.77 0.00053 0.08413 
160327 1700012H17Rik 367.81 397.98 317.76 3509.98 1887.92 1267.01 5.65 0.00026 0.08153 
2340484 Unc13d 274.09 280.67 1171.16 2492.29 3366.98 1897.98 5.61 0.00386 0.12220 
5720609 Lyz 355.62 371.78 610.36 1701.37 2622.91 2588.35 5.23 0.00007 0.06715 
1340092 Unc13d 256.82 252.24 755.13 2137.08 2353.34 1211.12 4.99 0.00211 0.10870 
5960717 C230009C22Rik 369.61 404.06 466.08 3182.19 2818.14 921.41 4.91 0.00179 0.10232 
7570228 Chd2 269.20 270.92 240.68 455.97 1911.28 2187.25 4.77 0.00606 0.14063 
1570594 Socs3 1271.77 1272.89 3891.32 13433.56 7015.73 7095.24 4.73 0.00292 0.11416 
6940132 A230050P20Rik 807.34 875.24 1334.95 8202.50 4610.44 2622.14 4.72 0.00128 0.09534 
4880026 Tspan17 290.23 311.85 533.15 4201.84 1270.65 887.80 4.61 0.00702 0.14724 






















































































































































4150725 Ctsz 840.91 738.73 2187.25 7425.53 4503.58 3403.05 4.38 0.00309 0.11416 
150458 Trp53rk 458.18 409.77 277.21 1917.66 2082.78 1026.80 4.29 0.00041 0.08299 
4540626 Tmem38b 790.50 805.67 280.14 3551.82 1980.80 1806.46 4.15 0.00361 0.12045 
6450438 Stk38l 228.80 225.86 835.59 1305.11 2227.71 1005.70 4.08 0.00920 0.16242 
7040446 Gfi1 344.45 371.11 622.49 2573.71 1688.22 1178.57 4.01 0.00079 0.08614 
450615 Bbc3 1096.15 886.40 4279.67 12257.64 6436.76 3363.15 4.00 0.02527 0.22570 
6330717 LOC100044776 773.77 856.84 1502.20 5399.21 3953.60 2897.70 3.96 0.00060 0.08413 
6860253 H13 1476.47 1365.00 263.33 3886.80 3006.20 2820.69 3.96 0.01882 0.20295 
3450091 Ctsz 743.48 674.68 1745.53 5793.72 3914.03 2397.59 3.96 0.00367 0.12071 
1110202 Camkk2 1579.67 1599.46 1961.20 10155.45 7161.22 4152.41 3.94 0.00057 0.08413 
6200719 Acss1 410.76 446.32 252.09 1630.10 1529.18 1126.99 3.93 0.00018 0.07378 
4540564 Dok2 261.14 265.47 342.33 1220.66 1229.69 881.23 3.82 0.00003 0.06115 
130634 Ddit4 568.31 588.80 1092.67 3363.15 2332.50 2439.05 3.74 0.00042 0.08299 
1050092 Serpina3g 267.80 262.82 247.66 568.66 1324.19 1180.30 3.71 0.00069 0.08413 
6580021 Mpo 3535.14 3506.52 3883.81 9975.33 12586.18 17879.26 3.60 0.00010 0.07378 
7510390 4933439C20Rik 788.54 832.69 550.99 3261.82 2910.35 1664.35 3.52 0.00058 0.08413 
270673 Acads 1903.60 2058.83 7292.12 15463.33 11386.26 7088.47 3.52 0.01486 0.18482 
3520546 Emp3 716.26 763.21 1184.15 2313.10 3998.36 2731.26 3.39 0.00048 0.08413 






















































































































































4200204 Sh3bp2 711.78 727.29 4035.31 6692.16 4543.87 2679.31 3.39 0.04430 0.26916 
4900403 Gnas 462.38 502.92 270.39 818.76 2231.59 1330.63 3.38 0.00380 0.12168 
2940681 Gata2 3451.52 3246.33 4606.56 16151.05 8857.75 13501.76 3.34 0.00035 0.08299 
6660634 Irf1 2094.55 2194.27 3858.86 11473.01 7184.64 7955.19 3.33 0.00072 0.08413 
1470170 Ccbl1 359.57 360.48 607.53 2017.24 1393.67 1033.32 3.33 0.00102 0.09198 
7160044 Cyth4 1958.18 1977.98 6589.56 9936.96 11345.42 8337.98 3.33 0.00871 0.15965 
4060593 Vangl2 450.57 481.80 579.40 1761.05 1908.88 1337.61 3.29 0.00005 0.06115 
6620685 Lgals8 516.74 482.07 781.30 2691.01 2203.52 1162.80 3.28 0.00195 0.10631 
4390239 Fcho1 294.88 295.02 491.64 1180.30 1517.40 831.36 3.27 0.00082 0.08622 
7380630 E330016A19Rik 745.37 749.89 1608.78 2546.40 3501.82 3451.52 3.25 0.00150 0.09965 
2570672 Atp2a3 1558.48 1620.16 5155.74 10012.60 6948.49 6383.68 3.24 0.00999 0.16502 
2480343 A430106G13Rik 295.93 318.74 1230.25 1299.75 1624.65 1849.68 3.23 0.01761 0.19827 
3830524 Magee1 400.86 420.21 2221.63 2790.58 2117.67 2014.87 3.17 0.03826 0.25410 
5270209 C330013J21Rik 222.12 222.64 390.58 1006.01 1032.91 591.39 3.17 0.00131 0.09534 
3710136 2310033F14Rik 1221.39 1252.03 3535.14 9071.22 4757.79 3944.45 3.16 0.01296 0.17741 
6900465 Plcb2 629.39 630.28 1063.78 3410.85 2131.37 1817.44 3.15 0.00125 0.09486 
2450113 Stab2 421.05 434.95 323.07 2382.44 1109.34 641.20 3.06 0.00979 0.16491 
2340349 Aldh2 6097.19 5775.55 12288.13 28741.38 22247.96 19029.61 3.04 0.00190 0.10618 






















































































































































1450333 Clec7a 246.66 231.57 251.49 753.09 821.82 648.83 3.03 0.00002 0.06115 
130370 LOC677144 394.51 422.19 1013.27 2721.83 1358.65 1255.98 3.02 0.01020 0.16502 
7400397 D530007E13Rik 328.70 334.42 493.41 1864.39 925.16 862.91 3.02 0.00228 0.11264 
940541 Fcrls 423.85 433.03 326.64 1168.86 1097.15 1270.86 3.01 0.00004 0.06115 
1230040 5730525O22Rik 890.26 1037.22 2213.81 6006.11 3727.42 2353.34 2.95 0.01115 0.17066 
6590167 Fcgrt 405.36 404.52 274.40 1159.82 1011.28 975.14 2.94 0.00013 0.07378 
4850594 Hmha1 2110.48 2313.75 4046.22 9601.63 8702.41 5933.97 2.93 0.00160 0.10081 
2350017 Hspa1a 493.41 475.21 231.57 1214.61 822.78 1340.56 2.91 0.00309 0.11416 
6560703 H6pd 716.00 699.21 2592.43 3310.16 3322.62 2883.86 2.90 0.01873 0.20279 
3310400 Gp5 230.57 235.28 809.52 910.10 1138.43 1014.42 2.88 0.01673 0.19343 
4390022 Lrrc28 347.19 351.32 621.78 1485.51 1318.57 925.32 2.88 0.00140 0.09834 
6520075 Ier3 4913.47 5294.77 8125.00 23512.67 17426.03 12104.34 2.86 0.00170 0.10205 
6180411 Gltp 449.79 447.08 1411.06 2998.87 1915.51 1137.06 2.84 0.02802 0.23120 
2810685 Glipr1 416.41 393.17 377.65 842.75 1621.14 1034.60 2.84 0.00061 0.08413 
5270608 Vav1 1510.09 1639.32 2461.14 4689.37 6471.30 4577.63 2.84 0.00052 0.08413 
5270279 Alox5ap 958.02 900.19 2103.18 2773.87 4134.68 3553.41 2.82 0.00415 0.12608 
7320181 Slc39a11 282.78 273.46 615.90 1484.09 973.76 727.23 2.80 0.00742 0.15057 
1990437 Stac3 266.61 257.08 244.40 1094.18 776.19 429.61 2.79 0.00306 0.11416 






















































































































































60673 Pip4k2c 380.48 390.15 1061.17 1529.18 1467.00 1523.20 2.79 0.00777 0.15359 
940309 Mpo 11146.78 10513.86 11450.52 31002.28 29213.21 31831.42 2.78 0.00001 0.06115 
1010196 Zfp341 303.61 315.71 246.30 806.63 856.22 719.41 2.76 0.00005 0.06115 
5360300 Lpl 2143.21 2229.51 5024.87 10126.49 7221.37 6887.72 2.76 0.00509 0.13498 
5960347 Als2 1007.66 944.77 2432.73 3522.29 3504.36 3879.86 2.74 0.00551 0.13683 
5890110 Cbfa2t3h 485.30 469.23 402.02 880.60 1267.90 1667.39 2.73 0.00074 0.08538 
3420500 Oxct1 351.58 378.14 268.58 914.24 721.10 1094.46 2.72 0.00033 0.08299 
5860154 Lst1 643.90 674.92 767.84 1547.38 2280.48 1888.36 2.71 0.00013 0.07378 
2140221 Slc40a1 306.05 313.44 303.61 756.40 692.31 1107.46 2.71 0.00023 0.07845 
10730 Cbx6 665.35 708.29 1834.10 1605.21 4596.28 2323.10 2.71 0.02803 0.23120 
4010019 Ifitm1 356.81 359.28 544.95 898.00 1241.18 1242.20 2.71 0.00053 0.08413 
4890041 Ilvbl 2209.98 2353.92 3690.98 7054.43 8942.33 6003.37 2.70 0.00088 0.08899 
3800482 2310047C04Rik 617.41 574.54 1118.16 3343.13 1736.66 1333.22 2.69 0.01002 0.16502 
4920600 C230071H18Rik 310.77 317.44 227.28 827.79 700.74 745.87 2.68 0.00012 0.07378 
7040307 2810410C14Rik 392.77 434.72 274.21 667.64 2151.06 621.87 2.67 0.02403 0.22170 
3450180 Tmem176b 484.93 401.78 1307.22 1795.99 1819.34 1480.76 2.67 0.01421 0.18086 
1030682 Slc11a2 312.71 310.94 229.85 980.74 638.37 677.16 2.67 0.00047 0.08413 
3420139 Il1r2 218.76 219.05 543.73 732.41 813.37 828.45 2.67 0.00626 0.14207 






















































































































































2070243 Aldh5a1 784.40 745.37 1760.07 3104.34 2740.18 2290.93 2.67 0.00513 0.13498 
4180647 Zkscan6 1499.96 1566.12 406.21 2921.90 2817.22 2180.62 2.66 0.03059 0.23812 
2900327 Pfkfb4 417.64 478.62 1338.32 1775.55 2484.23 1139.38 2.66 0.02573 0.22570 
2470424 2310004H21Rik 602.50 665.60 1098.70 3264.73 1448.19 1745.21 2.66 0.00661 0.14406 
1500301 Tuba8 508.29 484.93 825.61 2550.60 1381.43 1065.07 2.64 0.00693 0.14652 
3400646 Sirpa 2027.71 2149.26 3108.64 6924.06 6811.32 5250.19 2.63 0.00042 0.08299 
6940040 Msi2h 884.37 1016.97 804.00 2794.07 2475.38 1872.08 2.62 0.00024 0.07845 
7610356 Dynll2 213.00 213.86 238.84 1308.94 263.93 560.47 2.61 0.03605 0.25022 
6420520 Fosb 525.66 547.15 1099.79 3474.18 1259.02 1275.56 2.60 0.02382 0.22105 
6270091 Stk17b 265.19 270.00 553.00 888.50 822.78 931.45 2.58 0.00282 0.11416 
1410113 Uap1l1 617.69 558.35 1404.71 2271.66 2471.12 1458.30 2.57 0.01110 0.17066 
5910681 Als2 890.52 860.13 2311.52 2960.76 3019.18 3298.44 2.55 0.01013 0.16502 
7200189 C330006A16Rik 1342.35 1374.58 3296.26 4966.77 6097.19 3311.78 2.55 0.01315 0.17818 
5340762 AW212394 332.27 332.81 325.22 1139.38 687.94 751.36 2.54 0.00047 0.08413 
540437 Nfatc2ip 320.78 318.92 491.26 1201.84 1021.97 641.49 2.50 0.00288 0.11416 
1030053 Mta2 4157.22 3896.60 10829.65 16542.26 13678.29 12139.00 2.50 0.01377 0.17917 
4850291 Pik3cg 260.95 268.90 448.50 1308.04 687.16 545.99 2.50 0.00986 0.16502 
3710215 Map2k7 444.15 457.98 701.29 2182.83 1308.04 773.66 2.49 0.01263 0.17711 






















































































































































6290768 Cd52 586.94 586.94 936.07 755.79 2793.40 2336.51 2.48 0.03595 0.25022 
5090445 Unc84b 1199.88 1121.46 2209.98 3425.66 4137.66 3163.46 2.47 0.00276 0.11406 
6330543 Glrx1 578.72 582.47 436.87 1298.59 1106.34 1542.85 2.47 0.00033 0.08299 
1770201 Serinc3 2286.66 2675.05 2687.78 8915.72 5165.93 5311.72 2.46 0.00114 0.09418 
2750594 Tmem51 553.95 569.17 400.25 1428.33 1817.44 720.98 2.46 0.00868 0.15965 
7000300 2900006A08Rik 334.92 319.99 516.49 1167.80 1091.51 643.81 2.46 0.00357 0.12013 
270228 Stard5 330.04 330.04 459.85 1159.60 1029.96 620.98 2.46 0.00243 0.11313 
4050112 Glrx 533.15 527.00 303.30 1039.52 813.93 1462.01 2.44 0.00439 0.12808 
5560470 Psap 2675.05 2931.87 6700.35 10964.97 8759.81 7937.85 2.44 0.01007 0.16502 
1230612 Aqp1 465.05 478.29 726.76 1470.72 1495.44 1058.21 2.43 0.00117 0.09418 
4180458 Etfa 980.22 1097.15 1627.98 4270.28 2124.81 2765.13 2.43 0.00474 0.13086 
5290170 Zfp180 737.26 821.97 2332.50 3953.60 2540.88 2013.08 2.43 0.03328 0.24207 
2140753 Grina 930.84 962.16 1122.32 1904.34 3324.55 2265.21 2.43 0.00098 0.09054 
5960341 Msrb2 525.39 466.33 582.00 1973.25 1106.62 928.62 2.42 0.00349 0.11952 
6250291 Rpia 416.98 425.81 440.02 1477.21 893.91 838.26 2.42 0.00112 0.09418 
3310091 LOC100048589 1255.62 1213.55 1111.72 2796.02 3017.69 2839.62 2.42 0.00004 0.06115 
4480093 LOC225897 1999.61 2010.75 2663.46 6107.17 6011.72 4125.31 2.42 0.00070 0.08413 
6580711 LOC100044172 817.17 857.21 2498.83 2219.09 3572.96 3108.64 2.41 0.02707 0.22755 






















































































































































3170577 Pla2g15 2871.81 2796.34 7473.80 10608.51 10829.65 7239.23 2.40 0.01803 0.19933 
6650477 Gimap6 1630.89 1835.12 4274.85 6075.00 6940.70 4112.37 2.38 0.01725 0.19544 
3420689 EG665369 564.30 513.53 1065.72 1541.44 1648.03 1647.11 2.38 0.00344 0.11945 
7330026 Egr2 358.03 355.36 300.41 932.05 492.95 1120.51 2.38 0.00535 0.13600 
5340270 Epc1 811.98 851.12 1310.72 4656.54 2257.81 1155.51 2.38 0.04062 0.25987 
2060373 Cd79b 672.24 636.28 367.02 2151.57 1103.85 883.40 2.37 0.01541 0.18801 
6900632 1810026J23Rik 732.41 806.84 1948.78 3087.67 2487.88 1987.68 2.37 0.01682 0.19343 
2940504 Ncf4 225.85 238.01 348.42 473.75 623.45 836.70 2.36 0.00265 0.11406 
3360138 Irf1 494.58 486.81 720.98 1408.29 1141.69 1423.08 2.36 0.00060 0.08413 
6290193 2510010K19Rik 519.27 515.93 929.13 1651.44 1800.59 1102.20 2.36 0.00486 0.13213 
6280168 Mpo 526.28 528.24 452.79 1190.50 1189.41 1168.86 2.36 0.00005 0.06115 
7330110 Crtc3 485.30 458.29 474.27 1982.96 945.96 739.13 2.36 0.01044 0.16624 
2900139 Ube2e2 538.54 502.92 257.20 1324.48 961.74 718.02 2.36 0.01013 0.16502 
7000497 Ssr1 876.59 956.77 1315.87 2579.23 2729.11 2055.49 2.36 0.00067 0.08413 
3120563 Fbf1 560.03 543.83 394.18 2212.62 1085.54 654.93 2.36 0.02476 0.22472 
3800603 Slc22a3 259.33 238.26 371.88 1017.91 651.15 452.17 2.35 0.00734 0.14998 
7100392 Pop1 254.59 251.38 332.80 825.25 640.46 525.00 2.35 0.00084 0.08736 
110717 AI428936 333.19 363.03 302.05 815.43 884.37 656.69 2.35 0.00020 0.07472 






















































































































































2900255 Wsb2 539.95 549.16 977.28 2112.29 1566.71 1132.64 2.35 0.00679 0.14539 
2370390 Krtcap3 652.96 694.71 381.31 1261.53 1609.28 1100.95 2.35 0.00315 0.11550 
4390148 Rhox5 401.80 398.74 389.03 1198.64 1038.47 630.86 2.33 0.00199 0.10681 
3800630 Fbxl20 523.12 533.15 673.60 2364.42 1070.59 929.80 2.32 0.01210 0.17462 
1070224 Emp3 255.03 263.50 224.43 495.00 657.36 572.78 2.31 0.00018 0.07378 
3140279 A130052D22 230.50 229.90 687.66 801.98 964.60 581.93 2.31 0.03362 0.24290 
10402 Trim25 2509.13 2037.49 3553.41 11295.76 3715.45 5306.50 2.31 0.02620 0.22613 
3800601 Muted 3448.87 3556.62 2173.05 5736.32 8954.25 6293.42 2.30 0.00290 0.11416 
150209 A430006M23Rik 321.02 334.22 311.77 662.19 994.99 614.57 2.30 0.00081 0.08614 
1710754 Ctsc 648.38 635.17 470.52 1383.33 1101.09 1535.67 2.29 0.00066 0.08413 
1940608 Lyzs 224.43 218.38 255.46 442.36 649.82 522.49 2.29 0.00039 0.08299 
1070152 Stxbp2 3969.90 3775.46 4718.20 7837.02 10414.45 10372.06 2.29 0.00034 0.08299 
2370437 BC031781 1583.49 1775.75 1041.55 5867.11 3089.98 1925.44 2.28 0.02621 0.22613 
4040563 4631409F12Rik 1031.10 1094.97 1256.64 3998.36 2351.74 1791.89 2.28 0.00557 0.13683 
2030382 A930023F12Rik 255.98 272.18 277.70 662.82 492.38 700.44 2.28 0.00032 0.08299 
6250600 Cdkn2d 468.58 454.39 1241.35 2397.59 1408.29 923.51 2.28 0.04857 0.27915 
6130014 Iqgap2 1964.18 2137.08 1228.52 6576.75 2894.81 3171.53 2.27 0.01550 0.18837 
5050437 Ccrk 403.76 440.73 762.90 1275.82 1693.28 730.85 2.27 0.01678 0.19343 






















































































































































2030368 9130404D08Rik 761.20 739.13 1178.57 2034.09 2229.51 1691.25 2.26 0.00145 0.09920 
3840273 Zzz3 545.01 607.49 794.02 1486.79 1505.84 1338.32 2.25 0.00040 0.08299 
2570451 Mrps23 969.60 902.77 1710.25 3193.38 2422.83 2203.52 2.25 0.00492 0.13223 
2570187 Zfp87 354.62 346.95 619.92 1329.30 1062.04 614.38 2.25 0.01369 0.17917 
290632 Axin1 5243.75 5162.52 16829.94 17686.21 19844.03 14711.51 2.25 0.04079 0.26008 
6940324 Rassf4 224.20 235.83 249.88 554.77 629.07 426.88 2.24 0.00042 0.08299 
7330292 Mgst2 289.81 290.25 958.42 1009.15 1156.28 772.66 2.24 0.04687 0.27624 
450368 Rgs1 330.54 349.25 387.80 1151.15 623.59 696.72 2.24 0.00257 0.11406 
5080450 4833426J09Rik 1519.20 1650.08 641.78 2574.71 2583.13 2699.70 2.23 0.01504 0.18618 
5260433 Agtrap 391.11 379.20 635.72 1331.33 1092.60 722.28 2.23 0.00666 0.14406 
10717 B9d2 1079.77 1069.03 2220.78 3180.46 4152.41 2154.29 2.23 0.01632 0.19263 
70414 5730601F06Rik 2162.39 2320.43 6174.38 9376.47 7705.11 4721.98 2.22 0.04061 0.25987 
2230477 Mmp24 344.23 365.22 1027.97 1161.85 1441.35 844.86 2.22 0.03836 0.25410 
6620735 2310036D04Rik 464.28 452.47 1052.73 1631.83 1394.44 1061.74 2.22 0.01604 0.19159 
4900678 9030619K07Rik 2079.13 2224.37 3971.28 7497.79 6393.31 4178.46 2.22 0.01003 0.16502 
7330131 A630006E02Rik 453.13 426.73 327.98 665.87 1143.01 903.00 2.21 0.00227 0.11264 
4220008 Tmem81 380.01 377.59 290.71 750.84 882.41 678.36 2.21 0.00045 0.08413 
5290402 4933407N01Rik 365.34 383.16 364.38 1394.90 520.84 750.38 2.20 0.01351 0.17914 






















































































































































7000438 Bat2d 698.57 693.08 989.35 3331.39 1472.63 1038.94 2.20 0.03252 0.23995 
6270131 Pqlc1 764.18 710.97 346.90 1239.73 1011.97 1593.29 2.20 0.01302 0.17785 
6900470 Mrpl16 787.03 711.37 719.52 2005.61 1428.52 1489.51 2.20 0.00041 0.08299 
450561 Frmd4a 293.48 302.09 238.01 969.90 579.11 396.14 2.19 0.01081 0.16852 
4010670 2700033B16Rik 433.20 439.89 487.68 1472.63 769.78 860.54 2.19 0.00355 0.12013 
6290379 Sdad1 1385.78 1395.21 3564.67 5539.06 4102.78 3183.19 2.19 0.02946 0.23433 
3360048 Keap1 522.76 552.38 838.83 1656.06 1243.17 1231.73 2.19 0.00211 0.10870 
4010133 Cdc42ep4 1189.00 1163.37 1920.25 4786.91 2981.88 1944.65 2.19 0.01803 0.19933 
630091 Nfkbid 621.39 617.69 985.41 1527.41 1767.68 1461.32 2.18 0.00159 0.10081 
2190066 Tmem38b 398.57 390.95 253.61 833.89 676.75 730.13 2.18 0.00141 0.09834 
2100497 LOC621823 375.65 351.42 552.62 1206.05 830.08 755.94 2.18 0.00343 0.11945 
1170170 Nfe2 934.40 996.34 599.20 1545.17 1764.74 2081.65 2.17 0.00243 0.11313 
6660039 Mad 444.90 423.65 932.46 955.01 1470.72 1268.89 2.16 0.01432 0.18175 
1010601 Napa 565.37 522.09 535.24 2496.16 981.63 652.20 2.16 0.04718 0.27730 
6110577 1110003E01Rik 623.63 592.94 830.25 1890.20 1287.91 1274.51 2.16 0.00178 0.10205 
1510669 Acy1 842.34 864.27 1407.39 2435.44 2244.97 1863.28 2.15 0.00274 0.11406 
4010097 Map4k1 558.74 557.57 1463.58 1247.08 2367.69 1523.49 2.14 0.03965 0.25599 
3460762 Rasgrp4 794.74 823.88 1560.62 2335.16 2814.25 1510.09 2.13 0.01587 0.19083 






















































































































































4060240 Ptpn6 1902.08 1958.18 2009.63 3233.71 4683.26 4774.31 2.13 0.00078 0.08614 
6760546 Rbbp5 326.49 335.92 367.75 574.97 933.42 725.73 2.13 0.00118 0.09418 
460692 Bcl11a 482.70 412.10 471.60 870.51 860.54 1206.05 2.13 0.00066 0.08413 
3390452 E330019I03Rik 223.78 226.06 549.58 947.67 574.54 488.41 2.12 0.03647 0.25153 
6510041 Frmd4a 291.13 301.54 241.90 904.02 573.43 390.00 2.12 0.01018 0.16502 
130661 5830436K05RIK 241.20 253.50 239.45 461.90 569.42 529.51 2.12 0.00016 0.07378 
5310360 Stat3 4818.48 4436.46 4963.18 14145.48 8796.27 8015.52 2.11 0.00277 0.11406 
1090180 Arhgdib 1187.16 1255.51 1424.35 2509.13 2708.39 2936.27 2.11 0.00019 0.07378 
5420142 Churc1 312.50 317.16 244.04 1065.07 422.33 501.95 2.11 0.01943 0.20497 
3140465 6330548G22Rik 1139.38 1088.41 1137.06 3572.96 2265.21 1624.11 2.10 0.00730 0.14946 
3420528 4933407N01Rik 394.78 406.21 330.93 1280.35 540.84 711.54 2.10 0.01239 0.17647 
3460392 Mpl 799.35 732.41 1197.47 1718.14 1975.22 1915.51 2.10 0.00176 0.10205 
4220193 Pgpep1 405.04 423.49 787.68 811.50 1230.72 1247.53 2.10 0.01163 0.17309 
6620180 Fnbp1 11512.36 13207.85 18821.72 46164.40 26090.96 21892.28 2.10 0.01380 0.17917 
6860609 Rbp1 1552.25 1681.57 1516.40 4582.08 3339.36 2370.40 2.09 0.00390 0.12246 
2120014 Pole3 1816.07 1945.69 3632.38 7926.70 5186.75 2846.08 2.09 0.04381 0.26863 
5670634 Synpo 785.59 827.23 1015.40 2238.61 1750.98 1533.53 2.09 0.00110 0.09418 
3170672 Sergef 284.67 283.27 377.65 613.78 819.10 548.90 2.08 0.00167 0.10205 






















































































































































2690253 Angptl6 252.65 255.96 447.83 751.36 953.74 365.37 2.08 0.03508 0.24736 
1400523 Smap2 2563.26 2393.66 4869.62 4700.35 7278.26 7883.73 2.08 0.01623 0.19247 
4540278 Pcbd2 787.38 786.38 1208.07 1898.39 2222.16 1585.96 2.08 0.00273 0.11406 
4640168 3110001D03Rik 2150.54 2063.27 4543.87 7509.61 4869.62 4915.77 2.07 0.02047 0.20904 
50079 Hist1h1c 535.41 527.80 1087.47 1730.90 1052.61 1492.93 2.07 0.01756 0.19814 
4760041 Tmem160 1750.16 1792.71 2870.46 6262.75 3847.39 3304.20 2.07 0.01166 0.17309 
4280056 Trib3 380.19 349.69 511.53 622.90 1058.76 907.72 2.06 0.00449 0.12896 
2810315 Chst3 280.76 286.10 238.53 650.80 568.95 454.97 2.06 0.00080 0.08614 
450088 9830134C10Rik 381.41 391.36 362.47 674.34 871.48 806.63 2.06 0.00029 0.08299 
3120619 Myom1 370.44 350.67 286.59 1369.24 452.44 521.93 2.06 0.04198 0.26309 
6650458 Nfkbiz 741.01 791.55 517.58 1354.84 1145.18 1698.94 2.06 0.00304 0.11416 
4490239 Znfx1 614.17 623.59 1490.88 2108.10 1413.95 1662.30 2.05 0.02773 0.23041 
6100523 Cugbp2 1588.43 1498.82 1212.23 3899.94 2490.17 2561.15 2.05 0.00261 0.11406 
360270 Ppm1b 5365.70 4601.54 8058.71 18365.09 12288.13 7595.70 2.05 0.02505 0.22570 
360524 2700087H15Rik 1563.58 1674.44 2804.24 2639.88 6135.43 3874.86 2.04 0.02558 0.22570 
1980619 Ppm1b 5033.81 4555.59 7946.54 18470.99 11625.30 7230.98 2.04 0.03032 0.23744 
3990228 Tmem44 541.10 553.95 628.74 1429.02 1195.36 934.33 2.04 0.00121 0.09486 
3310538 Pcbd2 1151.41 1300.96 2025.15 3221.51 2979.68 2669.10 2.04 0.00364 0.12051 






















































































































































4200224 Helb 767.16 753.46 1335.46 2332.50 1754.02 1588.09 2.03 0.00788 0.15486 
1110095 Muted 6309.46 5634.74 3590.70 8954.25 12621.22 9499.90 2.03 0.00569 0.13749 
2030259 Depdc5 351.47 337.10 445.24 977.17 739.86 607.45 2.03 0.00262 0.11406 
6220044 Dennd1c 219.79 216.71 310.10 390.49 563.84 558.00 2.03 0.00295 0.11416 
7100291 Hoxa5 700.10 660.61 1619.41 1570.18 1500.60 2639.88 2.03 0.03943 0.25555 
20064 Capg 666.29 656.60 686.11 1591.92 1265.39 1236.88 2.02 0.00036 0.08299 
4780184 Ly6e 596.81 648.01 676.75 874.38 1309.81 1895.00 2.02 0.00902 0.16162 
150035 Fut8 812.70 844.72 775.73 1455.46 1551.18 1955.62 2.02 0.00048 0.08413 
6980187 Gria3 548.71 490.57 400.66 862.91 1004.58 1031.10 2.02 0.00069 0.08413 
4610300 Pet112l 289.90 291.04 224.43 584.72 592.97 450.12 2.02 0.00108 0.09406 
5220279 Mt1 4089.44 4209.24 4498.59 6225.31 10372.06 9872.41 2.02 0.00282 0.11416 
2070246 4733401I05Rik 311.13 321.14 810.19 768.82 1033.32 836.98 2.02 0.03435 0.24477 
1690497 2310043N10Rik 525.10 535.51 568.55 1524.46 1051.82 813.55 2.01 0.00428 0.12775 
160086 Vamp1 212.61 212.93 230.72 545.01 256.21 606.54 2.01 0.01882 0.20295 
4050437 Chst3 285.24 308.38 227.63 624.43 557.40 465.99 2.01 0.00114 0.09418 
3610162 Dbr1 739.34 712.45 724.53 1842.34 993.06 1686.85 2.01 0.00527 0.13540 
6660707 Klhl5 529.25 557.07 523.35 332.03 242.45 239.44 0.50 0.00079 0.08614 
2370446 Eif5a 596.22 741.33 732.09 259.62 405.50 383.80 0.50 0.00254 0.11406 






















































































































































2940164 Rbm13 3126.30 2817.68 1389.28 930.44 1047.92 1552.25 0.50 0.02601 0.22586 
5270687 E330020G21Rik 4714.91 4894.25 1980.80 1688.22 1494.47 2238.61 0.50 0.03274 0.24080 
4060609 9830005G06Rik 698.66 717.64 471.16 372.70 254.06 304.64 0.50 0.00357 0.12013 
4290458 F730003H07Rik 867.52 835.59 653.84 336.11 451.80 380.71 0.50 0.00107 0.09406 
2750682 Chd1 1919.57 2191.34 1651.65 468.10 1455.46 1239.73 0.50 0.04902 0.28042 
6590286 P2ry5 10101.38 11160.89 7074.16 3390.57 5102.58 5532.61 0.49 0.00616 0.14188 
6840433 Npm1 25925.63 24957.99 11716.57 13347.47 5964.96 11427.53 0.49 0.04539 0.27169 
430576 Ptprm 866.52 873.94 469.78 394.47 315.97 341.58 0.49 0.00736 0.15029 
3170397 LOC100045967 3400.51 3299.86 1681.57 1055.81 1231.26 1733.67 0.49 0.01767 0.19848 
3710242 Arpc3 3039.31 2871.81 1301.73 774.60 1051.05 1661.58 0.49 0.04273 0.26457 
6860333 A130099L09Rik 741.52 721.36 691.23 451.15 300.71 322.88 0.49 0.00108 0.09406 
4490168 Wdr74 3163.46 3120.79 2559.53 942.27 1370.43 2315.24 0.49 0.01662 0.19343 
2030091 Rbm9 595.00 549.44 401.04 248.41 244.00 254.74 0.49 0.00092 0.09018 
5270452 Tiam1 3596.56 3369.53 2392.86 1724.77 1283.19 1530.37 0.49 0.00194 0.10631 
6510553 Gnb1 1177.33 1323.70 749.53 364.54 504.10 741.66 0.49 0.01598 0.19115 
7380364 Carhsp1 1825.10 1726.53 1120.32 845.42 601.51 808.79 0.49 0.00409 0.12546 
1500768 Dcbld1 881.68 921.93 710.39 342.22 462.24 422.83 0.49 0.00086 0.08804 
2750221 Bat2d 960.96 914.15 550.45 434.28 464.04 276.76 0.49 0.01036 0.16598 






















































































































































1820224 Marcks 1643.34 1516.90 1400.90 690.10 769.78 743.61 0.48 0.00016 0.07378 
6840482 6330581N18Rik 1759.07 1866.67 1492.46 1102.65 652.11 770.65 0.48 0.00257 0.11406 
670026 LOC100046650 2297.80 1977.33 1323.49 708.06 792.97 1207.60 0.48 0.00844 0.15815 
1990021 
ENSMUSG00000
068790 2670.29 2471.12 1368.56 1498.25 717.76 946.62 0.48 0.02261 0.21581 
1850408 D130078K04Rik 1084.35 964.25 665.60 400.18 535.18 365.51 0.48 0.00370 0.12071 
3130603 A630042L21Rik 905.55 972.20 726.43 435.50 328.63 502.52 0.48 0.00175 0.10205 
2470195 Pcbp1 1836.19 1624.65 868.06 445.32 618.43 1054.37 0.48 0.03496 0.24732 
3290164 LOC622994 2177.70 1925.44 1423.70 460.11 1029.03 1408.16 0.48 0.03984 0.25680 
5290189 Dync1h1 1146.89 1100.52 844.16 306.81 566.90 682.28 0.48 0.01284 0.17711 
2490255 Narg1 2952.95 2965.26 2159.93 869.84 1253.51 1921.50 0.48 0.01128 0.17166 
1990564 Txndc5 2098.55 2041.04 2308.43 728.35 1298.59 1153.44 0.48 0.00309 0.11416 
4040768 Rn18s 1901.37 1817.99 996.77 485.30 800.34 974.78 0.48 0.01978 0.20633 
2810634 Sept11 17879.26 21606.02 8833.80 7109.72 6844.10 7659.39 0.48 0.01508 0.18634 
1260164 Asns 2890.38 2628.47 1455.46 879.10 1145.47 1189.00 0.48 0.00819 0.15762 
6760538 Prkd3 2489.73 2256.11 1170.52 1058.21 786.83 853.91 0.48 0.01087 0.16911 
2100221 LOC270589 886.96 821.49 438.88 428.48 284.63 273.89 0.47 0.01212 0.17462 
2710544 Gli3 2158.49 2176.83 2145.13 1442.50 787.68 918.77 0.47 0.00274 0.11406 
7200240 Sap30 3082.42 3142.32 2155.21 946.15 1409.03 1614.79 0.47 0.00409 0.12546 
 
 






















































































































































1240564 Appbp2 10372.06 10952.90 5566.06 2765.13 4440.31 5274.55 0.47 0.01657 0.19343 
3140370 Nid1 1750.74 1931.27 804.44 791.97 728.73 480.40 0.47 0.02274 0.21601 
2510037 Alad 4342.34 4863.18 3233.71 1310.29 2177.70 2429.57 0.47 0.00613 0.14188 
3370487 Ext1 1651.44 1828.19 1439.70 415.02 1049.43 1011.63 0.47 0.02095 0.20988 
5890255 Cd93 2063.27 2121.89 798.74 642.94 587.08 937.03 0.47 0.03230 0.23952 
7330551 Sall4 835.39 826.20 335.28 291.95 270.71 291.60 0.46 0.01851 0.20217 
4880554 Cnih4 2341.05 2386.38 1591.44 872.82 975.52 1036.81 0.46 0.00098 0.09054 
6980025 Shroom2 3105.63 3111.46 1964.18 1122.03 1059.21 1551.18 0.46 0.00304 0.11416 
6940068 X99384 1487.66 1339.79 1286.74 755.13 501.51 657.07 0.46 0.00066 0.08413 
6900017 Bzw1 2699.70 2341.05 1549.32 581.05 827.39 1968.44 0.46 0.04597 0.27279 
2710328 C230070D10Rik 2452.64 2636.25 1318.94 871.72 1051.39 898.07 0.46 0.00566 0.13725 
5080114 D130047L08Rik 615.22 678.06 647.06 247.10 337.12 312.28 0.46 0.00030 0.08299 
450372 Bok 2243.17 1962.47 2329.19 842.41 945.04 1235.39 0.46 0.00060 0.08413 
2490113 Lin28 582.94 507.24 1264.77 284.55 375.37 333.39 0.46 0.01537 0.18801 
1580088 Ccnd2 3136.60 3274.47 1117.18 1268.72 792.66 1078.32 0.46 0.03699 0.25198 
6330445 Mogat2 698.27 716.26 772.59 307.48 344.58 344.01 0.46 0.00008 0.07262 
1030338 Atp5c1 6368.01 6622.65 3180.46 2130.52 1990.15 2951.52 0.45 0.01007 0.16502 
1980392 Galnt1 877.53 864.66 430.84 292.53 297.91 344.65 0.45 0.00638 0.14319 
 






















































































































































6130561 Plau 591.95 607.16 1015.68 290.16 318.30 362.12 0.45 0.00233 0.11289 
5860494 5830406C17Rik 720.72 714.55 744.67 308.67 309.08 365.72 0.45 0.00009 0.07378 
6520040 Heatr5a 873.21 861.10 382.87 308.69 338.81 248.31 0.45 0.01256 0.17711 
3190408 Mest 2336.51 2268.08 2692.25 814.69 1242.20 1239.92 0.44 0.00091 0.09005 
610253 Eno1 5634.74 5800.43 2535.02 1620.16 1583.49 2825.66 0.44 0.02029 0.20777 
7160725 C230029D21Rik 1927.75 2031.28 1732.36 916.31 746.70 842.07 0.44 0.00012 0.07378 
990435 Dynll1 10291.20 9023.06 3868.21 3603.73 2511.25 3356.93 0.44 0.01810 0.19965 
2060008 Rsrc2 728.78 808.42 297.75 232.77 248.64 250.78 0.44 0.01585 0.19081 
5810168 Nfatc3 1130.35 1175.78 641.45 381.38 408.68 445.95 0.43 0.00240 0.11289 
2710324 Aard 1019.03 979.84 1569.55 806.37 477.39 320.54 0.43 0.01264 0.17711 
130594 D930048N14Rik 3955.69 4780.48 3328.80 1258.10 2641.40 1476.47 0.43 0.00525 0.13540 
1690091 Vim 1234.81 1340.99 691.55 373.42 422.82 564.10 0.43 0.00465 0.13037 
6760008 Ypel5 911.49 971.94 324.82 296.64 240.04 313.88 0.43 0.02391 0.22145 
630600 Eif3eip 2897.70 2305.12 1008.12 681.32 712.86 1075.67 0.43 0.02099 0.20988 
3440343 Cap1 952.25 998.10 550.70 310.26 330.02 393.64 0.43 0.00225 0.11264 
70400 2610104A14Rik 976.16 981.84 429.50 285.06 294.88 376.63 0.43 0.00944 0.16333 
730739 Cep78 1612.75 1676.36 583.48 448.11 447.96 603.35 0.43 0.02232 0.21524 
6350044 Slc2a1 7385.06 7320.20 4586.46 2559.53 2795.69 2645.31 0.42 0.00083 0.08659 
 






















































































































































2030692 D130071N09 4811.10 5812.17 4894.25 1238.97 2857.82 2894.81 0.42 0.00885 0.16088 
6060376 Orc6l 1851.62 1697.73 735.92 604.11 426.77 659.04 0.42 0.01369 0.17917 
3290747 Bex2 3216.97 3492.91 2793.40 1537.72 1210.87 1237.43 0.42 0.00016 0.07378 
5290148 Setd5 1205.49 1197.63 449.89 258.50 347.01 527.75 0.42 0.02715 0.22765 
2350079 A730094H17Rik 2487.20 2977.58 857.76 866.90 685.15 774.89 0.42 0.02866 0.23278 
3990484 3110004L20Rik 1740.60 1768.32 1503.83 638.90 752.33 686.64 0.41 0.00007 0.06715 
1980487 4921506J03Rik 5465.30 6097.19 2894.81 1420.41 2074.70 2294.71 0.41 0.00649 0.14345 
3840300 E130012P04Rik 614.48 619.99 597.68 230.44 222.10 311.03 0.41 0.00018 0.07378 
780093 Cox6b1 2419.34 2278.11 706.23 421.00 672.78 956.54 0.41 0.04830 0.27829 
1740553 Raf1 3480.68 3104.34 1595.08 879.32 1028.61 1323.09 0.41 0.00604 0.14049 
3990500 5330408N05Rik 1674.44 1744.52 921.03 383.95 799.68 586.01 0.41 0.00823 0.15777 
6940136 Mllt4 5682.19 6214.35 1527.41 1671.72 1208.77 1772.05 0.40 0.04637 0.27410 
1710504 Isg20l2 1376.83 1388.78 947.04 314.70 445.99 833.89 0.40 0.00957 0.16367 
4040037 Tpm4 16123.05 16050.96 9418.58 4319.04 4361.23 8234.12 0.40 0.00578 0.13838 
7610494 Ssr2 2892.86 3080.86 1975.85 654.93 1048.58 1614.26 0.40 0.00728 0.14946 
6450520 7530408C15Rik 4395.28 4543.87 5979.14 2324.44 2188.63 1465.30 0.40 0.00077 0.08610 
6510333 Sfrs1 10437.95 10069.31 3574.95 2311.52 1757.86 5593.79 0.39 0.04944 0.28050 
2570196 Soat1 1208.34 1418.84 341.34 292.44 301.24 400.31 0.39 0.03873 0.25410 
 






















































































































































6770356 Mest 7257.15 6954.87 7505.60 2006.52 2951.52 3837.83 0.39 0.00100 0.09078 
2000180 Prdx4 4698.57 4015.76 1915.51 884.61 1280.11 1913.65 0.39 0.01441 0.18232 
6290133 Endod1 1245.66 1289.43 950.12 398.92 462.24 488.60 0.39 0.00015 0.07378 
540390 Ssr3 4389.37 5190.62 2063.27 1184.91 1158.31 1982.96 0.39 0.01056 0.16696 
1690019 Mest 6712.69 6420.07 6332.16 1794.83 2574.71 3281.06 0.38 0.00063 0.08413 
5570333 LOC386144 3095.62 2991.75 1248.65 678.60 1032.65 894.26 0.38 0.00813 0.15702 
2480059 Anxa5 1860.18 1826.27 1097.72 649.96 544.17 558.57 0.38 0.00065 0.08413 
7320152 Ube2e3 1295.03 1362.27 721.62 323.36 405.88 510.67 0.37 0.00227 0.11264 
3140687 Nrp 8095.56 7848.63 3580.46 2966.49 1759.07 2164.00 0.37 0.00577 0.13838 
4640338 Klf7 6815.14 6440.30 2119.51 1837.55 1362.56 1775.95 0.36 0.01521 0.18700 
4900025 LOC386360 2674.01 2821.67 818.70 614.92 692.06 641.81 0.35 0.01562 0.18903 
2690435 Peg3 9670.34 9364.16 5634.74 2278.11 2916.39 3233.71 0.35 0.00069 0.08413 
2940047 C630024B01Rik 3770.39 4454.55 2341.05 905.09 1403.51 1277.33 0.35 0.00125 0.09486 
2490274 3010031K01Rik 1832.88 1997.96 1592.41 554.77 1193.85 352.82 0.34 0.00843 0.15815 
1050095 Upp1 2688.46 3011.33 1175.38 522.09 862.75 835.59 0.34 0.00614 0.14188 
160519 Tmem65 2148.18 2243.17 1723.06 640.14 658.88 770.88 0.34 0.00004 0.06115 
7610433 Nsfl1c 2443.26 2479.40 1029.14 289.11 604.30 1394.90 0.34 0.03952 0.25563 
610092 Grm6 1041.87 1021.59 538.14 234.23 245.66 386.25 0.34 0.00213 0.10902 
 






















































































































































3890008 E230020D15Rik 3104.34 3249.09 905.42 690.95 703.45 695.84 0.33 0.01398 0.17957 
5360367 mtDNA_COXIII 6692.16 7230.98 1772.64 1607.45 1076.52 1576.09 0.32 0.01915 0.20497 
4060521 Xist 2281.13 2399.39 1088.77 471.60 543.83 684.85 0.31 0.00157 0.10062 
5290523 LOC280097 1291.91 1057.60 451.94 261.24 258.45 260.97 0.31 0.00302 0.11416 
5900392 Xist 3412.69 3236.13 1414.96 559.75 637.74 976.16 0.28 0.00240 0.11289 
3520240 Rn18s 7124.23 5906.61 1959.66 495.18 1499.32 2077.42 0.27 0.02537 0.22570 
630241 LOC386288 2382.44 2089.66 555.33 291.29 321.20 330.88 0.22 0.00526 0.13540 
630519 Mid1 4744.18 4606.56 1153.44 1641.52 394.87 288.64 0.20 0.02222 0.21524 
5260431 LOC100043402 3799.46 3167.20 923.10 280.66 466.51 480.63 0.18 0.00284 0.11416 
4220386 LOC100041388 21340.58 19921.24 6750.41 1897.98 2517.94 2617.46 0.16 0.00072 0.08413 
2750066 Rn18s 4838.85 3979.86 1234.09 256.45 565.87 608.15 0.15 0.00257 0.11406 
6330047 LOC386112 8759.81 8220.00 2278.11 653.75 817.62 851.12 0.14 0.00099 0.09054 
650221 LOC385923 10686.55 9996.04 1148.23 739.96 644.95 623.63 0.13 0.01050 0.16671 
1230494 LOC386199 7713.92 6461.29 1345.22 329.65 595.85 642.00 0.12 0.00308 0.11416 





























































































































































FIG. S1. (A) Expression profiles of genes encoding HSC surface markers (Flk-1, c-Kit, 
CD31, CD34 and Sca-1) and lineage markers (E-cad, F4/80, Gr-1, CD4, CD8, 
Ter119 and CD19) over the course of HSC development. The X-axis shows gene names, and 
the Y-axis their relative expression. (B) Expression profile of genes (Twist1, Ccnd1 and 
Ifnar2) encoding HSC regulators during HSC development. The X-axis shows the 10 samples 
obtained at different sites at different stages, and the Y-axis indicates relative expression of 
each gene.  
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